Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

GGHCX vs JEHSX overlap: 59% of top holdings shared

Bottom line

How much do GGHCX and JEHSX overlap?

59% of their top holdings overlap by weight. 12 securities appear in both funds' top 25, making up 48.2% of GGHCX's assets and 48.3% of JEHSX's. They share a meaningful core but differ in the rest of the portfolio.

JEHSX holds far more positions (173 vs 82), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

GGHCXJEHSX
Weight overlap (top 25)59%
Shared holdings12
Weight in shared holdings48.2%48.3%
Total positions82173
Expense ratio1.07%1.04%
Holdings as ofJul 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Holdings GGHCX and JEHSX have in common

Holding% of GGHCX% of JEHSXOverlap
Eli Lilly and Co.10.59%14.30%10.59%
Johnson & Johnson6.76%6.33%6.33%
UnitedHealth Group Inc.6.17%5.95%5.95%
Merck & Co., Inc.4.59%4.21%4.21%
AbbVie Inc.4.03%5.28%4.03%
Gilead Sciences, Inc.3.63%2.95%2.95%
CVS Health Corp.2.52%0.98%0.98%
BrightSpring Health Services, Inc.2.20%0.88%0.88%
Cardinal Health, Inc.2.10%1.09%1.09%
Guardant Health, Inc.2.04%1.28%1.28%
Vertex Pharmaceuticals Inc.2.01%2.38%2.01%
Thermo Fisher Scientific Inc.1.55%2.67%1.55%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in GGHCX

  1. Invesco Private Prime Fund — 4.67%
  2. argenx SE — 3.24%
  3. Welltower Inc. — 2.34%
  4. Royalty Pharma PLC — 2.13%
  5. Invesco Private Government Fund — 1.80%
  6. Axsome Therapeutics, Inc. — 1.58%
  7. Edwards Lifesciences Corp. — 1.56%
  8. Invesco Treasury Portfolio — 1.56%
  9. BridgeBio Pharma, Inc. — 1.43%
  10. Waters Corp. — 1.41%
  11. IQVIA Holdings Inc. — 1.32%
  12. U C B S.a. — 1.24%
  13. Ligand Pharmaceuticals Inc. — 1.18%

Only in JEHSX

  1. Bristol-Myers Squibb Company — 2.22%
  2. Abbott Laboratories — 2.00%
  3. Intuitive Surgical Inc. — 1.98%
  4. Amgen Inc. — 1.90%
  5. Stryker Corporation — 1.87%
  6. Elevance Health Inc. — 1.63%
  7. Danaher Corporation — 1.51%
  8. Natera Inc. — 1.49%
  9. Royalty Pharma plc — 1.02%
  10. Tenet Healthcare Corporation — 0.99%
  11. Kymera Therapeutics Inc. — 0.93%
  12. Protagonist Therapeutics Inc. — 0.90%
  13. Moderna Inc. — 0.87%

Asset mix

Asset typeGGHCXJEHSX
Stocks97.5%99.0%
Cash & short-term funds8.8%0.9%
Bonds—0.1%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Country mix

CountryGGHCXJEHSX
US93.5%95.0%
NL3.4%1.0%
GB3.1%0.8%
CH2.7%0.3%
BE1.2%—
DK1.1%0.7%
IE0.6%0.9%
JP—0.5%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do GGHCX and JEHSX overlap?
About 59% by weight. 12 securities appear in both funds' top 25 holdings; they make up 48.2% of GGHCX's assets and 48.3% of JEHSX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do GGHCX and JEHSX have in common?
The largest shared holdings are Eli Lilly and Co., Johnson & Johnson, UnitedHealth Group Inc., Merck & Co., Inc., AbbVie Inc..
Should I own both GGHCX and JEHSX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, GGHCX or JEHSX?
JEHSX is broader, with 173 positions versus 82 for GGHCX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.